Browse All
Displaying 1 - 3 of 3
Author:Pardo, Gabriel Hauser, Stephen Bar-Or, Amit Gold, Ralf Montalban, Xavier Cohen, Jeffrey Robertson, Derrick Hersh, Carrie Naismith, Robert Deiva, Kumaran Bhatt, Alit Fu, Haoyi Boer, Ibolya Meuth, Sven Cross, Anne Gärtner, Jutta Kappos, Ludwig
Session Name:S31: Multiple Sclerosis: Therapeutics and Clinical Decision Making
Topic:Multiple Sclerosis
Program Number:S31.003
Author Institution:Oklahoma Medical Research Foundation, Oklahoma, USA, Oklahoma City, OK UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA, San Francisco, CA Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA Department of Neurology, Katholisches Klinikum Bochum, Ruhr-Universität Bochum, Bochum, Germany, Bochum, Germany Department of Neurology Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain, Barcelona, Spain Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA, Cleveland, OH Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, Florida, USA, Tampa, FL Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, United States, Las Vegas, NV Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri, USA, Saint Louis, MO Department of Pediatric Neurology, University Hospitals Paris Saclay, Hôpital Bicêtre, National Reference Center for Rare Inflammatory Brain and Spinal Diseases, Le Kremlin Bicêtre, France, Le Kremlin Bicêtre, France Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Department of Neurology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany, Duesseldorf, Germany Department of Neurology, Section of Neuroimmunology, Washington University School of Medicine, Saint Louis, Missouri, USA, Clayton, MO Department of Paediatrics and Adolescent Medicine, Division of Paediatric Neurology, University Medical Centre Göttingen, Georg August University Göttingen, Göttingen, Germany, Göttingen, Germany Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Organs, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland
Author:Naismith, Robert Zivadinov, Robert Morrow, Sarah Bass, Ann Obeidat, Ahmed Riser, Emily Wray, Sibyl Cristofanilli, Massimiliano Riolo, Jon Thorpe, Andrew Chaudhry, Burhan Mohiuddin, Kamran Cheng, Chun-Yen DeLuca, John
Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3
Program Number:P10.014
Author Institution:Washington University School of Medicine, St Louis, Missouri, Saint Louis, MO Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, Buffalo, NY London Health Sciences Centre, University Hospital, University of Western Ontario, London, Ontario, Canada, and Department of Clinical Neurological Sciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada, London, ON, Canada Neurology Center of San Antonio, San Antonio, Texas, San Antonio, TX Department of Neurology, The Medical College of Wisconsin, Milwaukee, Wisconsin, Milwaukee, WI Alabama Neurology Associates, Birmingham, Alabama, Birmingham, AL Hope Neurology MS Center, Knoxville, Tennessee, Knoxville, TN Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ Bristol Myers Squibb, Princeton, New Jersey, Amherst, NY Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers - New Jersey Medical School, Newark, New Jersey, West Orange, NJ
Author:Zivadinov, Robert Naismith, Robert Morrow, Sarah Bass, Ann Obeidat, Ahmed Riser, Emily Wray, Sibyl Riolo, Jon Chaudhry, Burhan Thorpe, Andrew Cheng, Chun-Yen DeLuca, John
Session Name:P11: Multiple Sclerosis: Epidemiology and Neuroimaging
Program Number:P11.017
Author Institution:Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, Buffalo, NY Washington University School of Medicine, St Louis, Missouri, Saint Louis, MO London Health Sciences Centre, University Hospital, University of Western Ontario, London, Ontario, Canada, and Department of Clinical Neurological Sciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada, London, ON, Canada Neurology Center of San Antonio, San Antonio, Texas, San Antonio, TX Medical College of Wisconsin, Milwaukee, Wisconsin, Milwaukee, WI Alabama Neurology Associates, Birmingham, Alabama, Birmingham, AL Hope Neurology MS Center, Knoxville, Tennessee, Knoxville, TN Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ Bristol Myers Squibb, Princeton, New Jersey , Princeton, NJ Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers - New Jersey Medical School, Newark, New Jersey, West Orange, NJ
